Grumpy-XL schreef op 6 juli 2023 08:31:
[...]
zie link holmes:
Jas Khera, Managing Director of WEP, said:
“It is great to be working with Pharming to support
making this drug available to patients diagnosed with APDS. This EAP will ensure that patients with a high unmet need have a secure and compliant supply of this treatment option available to them, which is in-keeping with WEP’s and Pharming’s shared goal of broadening access to critical, innovative medicines worldwide.”
Health care professionals can inquire for more details about leniolisib and the EAP by emailing WEP at
leeap@wepclinical.com